These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 18617735)

  • 1. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
    Watanabe T; Shiino A; Akiguchi I
    Dement Geriatr Cogn Disord; 2008; 26(1):89-100. PubMed ID: 18617735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
    Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
    Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease.
    Bartha R; Smith M; Rupsingh R; Rylett J; Wells JL; Borrie MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):786-93. PubMed ID: 18252268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
    Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dementias: diagnostic contribution of imaging and proton magnetic resonance spectroscopy].
    Arana E; Martínez-Granados B; Marti-Bonmati L; Martínez-Bisbal MC; Gil A; Blasco C; Celda B
    Neurologia; 2007 Jun; 22(5):267-74. PubMed ID: 17508300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging.
    Watanabe T; Shiino A; Akiguchi I
    Dement Geriatr Cogn Disord; 2010; 30(1):71-7. PubMed ID: 20689286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
    Azevedo D; Tatsch M; Hototian SR; Bazzarella MC; Castro CC; Bottino CM
    Dement Geriatr Cogn Disord; 2008; 25(6):491-500. PubMed ID: 18441524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal injury within language network in primary progressive aphasia.
    Catani M; Piccirilli M; Cherubini A; Tarducci R; Sciarma T; Gobbi G; Pelliccioli G; Petrillo SM; Senin U; Mecocci P
    Ann Neurol; 2003 Feb; 53(2):242-7. PubMed ID: 12557292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [1H-MR spectroscopic imaging in patients with clinically diagnosed Alzheimer's disease].
    Block W; Träber F; Kuhl CK; Fric M; Keller E; Lamerichs R; Rink H; Möller HJ; Schild HH
    Rofo; 1995 Sep; 163(3):230-7. PubMed ID: 7548870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of magnetic resonance spectroscopy in correlation with signal-to-noise ratio.
    Okada T; Sakamoto S; Nakamoto Y; Kohara N; Senda M
    Psychiatry Res; 2007 Nov; 156(2):169-74. PubMed ID: 17900878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton magnetic resonance spectroscopy detects a relative decrease of N-acetylaspartate in the hippocampus of patients with dementia with Lewy bodies.
    Xuan X; Ding M; Gong X
    J Neuroimaging; 2008 Apr; 18(2):137-41. PubMed ID: 18333837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex.
    Mihara M; Hattori N; Abe K; Sakoda S; Sawada T
    Neuroreport; 2006 Mar; 17(4):413-6. PubMed ID: 16514368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion tensor imaging correlates with proton magnetic resonance spectroscopy in posterior cingulate region of patients with Alzheimer's disease.
    Ding B; Chen KM; Ling HW; Zhang H; Chai WM; Li X; Wang T
    Dement Geriatr Cogn Disord; 2008; 25(3):218-25. PubMed ID: 18219201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical uses of proton magnetic resonance spectroscopy of the brain].
    Laubenberger J; Bayer S; Thiel T; Hennig J; Langer M
    Rofo; 1998 Jun; 168(6):539-49. PubMed ID: 9687944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
    Jessen F; Gür O; Block W; Ende G; Frölich L; Hammen T; Wiltfang J; Kucinski T; Jahn H; Heun R; Maier W; Kölsch H; Kornhuber J; Träber F
    Neurology; 2009 May; 72(20):1735-40. PubMed ID: 19451528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
    J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.